ULTRALIFE CORP (ULBI) - Form 8-K Summary
Business Context and Reporting Period
Ultralife Corporation, a Delaware corporation headquartered in Newark, New York, filed this Current Report on Form 8-K on August 7, 2026. The filing serves to announce the financial results for the second quarter ended June 30, 2026, via a press release attached as Exhibit 99.1.
Key Financial Metrics
The provided filing text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These details are referenced as being contained within the attached press release (Exhibit 99.1) but are not present in the 8-K cover document itself.
Material Changes
No material changes versus the prior comparable period are detailed in this text. The filing solely references the issuance of the Q2 2026 results press release.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, forward-looking guidance, specific risks, contingencies, or unusual items. Such information is expected to be found in the referenced press release.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated August 7, 2026) for actual Q2 2026 revenue and earnings figures.
- Verify year-over-year growth rates and margin trends in the attached press release.
- Check for any updated full-year 2026 guidance provided in the press release.
- Confirm the status of the company's liquidity and debt obligations as detailed in the full financial disclosure.